VV-GMCSF-Lact
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VV-GMCSF-Lact, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact [Phase 1]